/C O R R E C T I O N -- Octapharma/

In the news release, Fewer Blood Components Transfused with fibryga® Than Cryoprecipitate, Secondary Analysis of Prespecified FIBRES Subgroups Reports, issued 09-Sep-2026 by Octapharma over PR Newswire, we are advised by the company that the fifth paragraph, second sentence, should read...